Literature DB >> 25921669

Surgical resection and liver transplantation for hepatocellular carcinoma.

Mohamed E Akoad1, Elizabeth A Pomfret2.   

Abstract

With a better understanding of the natural history of hepatocellular carcinoma (HCC) and the improvement in imaging, locoregional therapies, surgical techniques, and postoperative care, patients with HCC are now managed by a multidisciplinary team. Partial hepatic resection can be curative in patients developing HCC in the setting of normal liver parenchyma and in patients with early cirrhosis but well-preserved hepatic synthetic function. Liver transplantation offers the best long-term survival and lowest incidence of tumor recurrence in select patients with HCC and underlying cirrhosis. This article discusses the role of surgical resection and liver transplantation in the management of HCC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Downstaging; Hepatic resection; Hepatocellular carcinoma; Liver transplantation; Living donor liver transplantation; Locoregional therapy

Mesh:

Substances:

Year:  2015        PMID: 25921669     DOI: 10.1016/j.cld.2015.01.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  32 in total

1.  RETRACTED ARTICLE: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p.

Authors:  Yu Fu; Limin Cai; Xuexue Lei; Dunwei Wang
Journal:  Cancer Cell Int       Date:  2019-12-16       Impact factor: 5.722

Review 2.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

Review 3.  Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation.

Authors:  Li-Ying Wang; Shu-Sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2018-07       Impact factor: 3.066

4.  Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablation.

Authors:  Maria Baimas-George; Michael Watson; Jesse Sulzer; Patrick Salibi; Keith J Murphy; David Levi; John B Martinie; Dionisios Vrochides; Erin H Baker; Lee Ocuin; David A Iannitti
Journal:  Surg Endosc       Date:  2020-06-25       Impact factor: 4.584

5.  A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis.

Authors:  Dashuai Yang; Yang Su; Fangrui Zhao; Chen Chen; Kailiang Zhao; Xiangyun Xiong; Youming Ding
Journal:  Front Surg       Date:  2022-06-16

6.  Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.

Authors:  Yu Zhang; Xiaofeng Zhang; Jinling Zhang; Bin Sun; Lulu Zheng; Jun Li; Sixiu Liu; Guodong Sui; Zhengfeng Yin
Journal:  Cancer Biol Ther       Date:  2016-09-23       Impact factor: 4.742

Review 7.  Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.

Authors:  Taizo Hibi; Osamu Itano; Masahiro Shinoda; Yuko Kitagawa
Journal:  Surg Today       Date:  2016-04-29       Impact factor: 2.549

8.  Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study.

Authors:  Parvez S Mantry; Ashwini Mehta; Bahar Madani; Alejandro Mejia; Islam Shahin
Journal:  J Gastrointest Oncol       Date:  2017-10

9.  Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics.

Authors:  Yang Zhang; Zhenyu Shu; Qin Ye; Junfa Chen; Jianguo Zhong; Hongyang Jiang; Cuiyun Wu; Taihen Yu; Peipei Pang; Tianshi Ma; Chunmiao Lin
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

10.  A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients.

Authors:  Tongdi Fang; Guo Long; Dong Wang; Xudong Liu; Liang Xiao; Xingyu Mi; Wenxin Su; Liuying Zhou; Ledu Zhou
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.